Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Alzheimer’s Drug Discovery Foundation

Investor type Venture Capital
Founders Leonard Lauder Ronald S. Lauder


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 24
Average round size
The average size of a deal this fund participated in
Portfolio companies 17
Rounds per year 1.00
Lead investments 9
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 6
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

Alzheimer's Drug Discovery Foundation is the famous Corporate Investor, which was founded in 1998. The main department of described Corporate Investor is located in the New York. The fund was located in North America if to be more exact in United States.

The fund was created by Leonard Lauder, Ronald S. Lauder.

This Alzheimer's Drug Discovery Foundation works on 11 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Genetics, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Metabolic Solutions Development, Oryzon Genomics, AgeneBio. The fund has specific favorite in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Alzheimer's Drug Discovery Foundation, startups are often financed by National Institutes of Health, Hopen Life Science Ventures, Dolby Family Ventures. The meaningful sponsors for the fund in investment in the same round are Dolby Family Ventures, W Fund, National Institutes of Health. In the next rounds fund is usually obtained by W Fund, Michael Montgomery, Kayne Anderson Capital Advisors.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Alzheimer’s Drug Discovery Foundation:
Typical Co-investors
Alzheimer’s Drug Discovery Foundation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Alzheimer’s Drug Discovery Foundation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arborview Capital Chevy Chase, Maryland, United States
Blue Crosss Blue Shield Of Florida Florida, Jacksonville, United States
CSC Upshot California, Palo Alto, United States
Inter-Asia Venture Management China, Hong Kong, Hong Kong Island
Jacaranda Partners California, Pasadena, United States
Juhua Group China, Hangzhou, Zhejiang
LSC Communications Chicago, Illinois, United States
MadDog Ventures Birmingham, Michigan, United States
Meruelo Capital Partners California, Downey, United States
Ocean Energy -
River Head Capital Chaoyang, China, Liaoning
SINBON Electronics Taipei, Taiwan
Solon Arizona, Tucson, United States
Stripe California, San Francisco, United States
Synthetic Genomics California, La Jolla, United States
Tailwind Capital New York, New York, United States
The Growth Fund Australia, New South Wales, Sydney
YSS Capital Central, Central Region, Singapore
YUL Ventures Canada, Montréal, Quebec

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Diagnostics
Life Science
29 Mar 2022 Massachusetts, United States

Altoida, Inc.

Application Software
Augmented Reality
Diagnostic Equipment
Health Care
Health Diagnostics
Medical Device
Other Healthcare Technology Systems
$498K08 Sep 2021 Washington, District of Columbia, United States

NeuroVision Imaging

Health Care
Health Diagnostics
Machine Learning
24 Aug 2021 Sacramento, California, United States

C. Light Technologies

Health Care
Medical Device
$251K04 Aug 2021 Berkeley, California, United States

NeuroVision Imaging

Health Care
Health Diagnostics
Machine Learning
02 Feb 2021 Sacramento, California, United States

LEXEO Therapeutics

Life Science
$85M07 Jan 2021 New York, United States

C2N Diagnostics

$2M24 Sep 2020 Saint Louis, Missouri, United States

Neuro Therapia

$8M22 Sep 2020 Illinois, United States

Biological Dynamics

Health Care
29 Jul 2020 San Diego, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Alzheimer’s Drug Discovery Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: